News & Announcements
You are here
| Announcement
| Announcement
The United States District Court for the Eastern District of Texas is accepting applications for the position of Tour Court Reporter. There are six divisional offices within the Eastern District of Texas: Beaumont, Lufkin, Marshall, Sherman,... more
| Announcement
The Judicial Conference Advisory Committees on Appellate, Bankruptcy, Criminal and Evidence Rules have proposed amendments to the following rules and forms and asked that they be circulated for comment:
Appellate Rules 3, 13, 26.1, 28 and 32;... more
| Announcement
Visit the 2017 John Hannah, Jr Award page for more information.
The John Hannah, Jr. Award is named in honor and in memory of Chief Judge John Hannah, Jr. and recognizes a Texas attorney who is... more
| Announcement
The United States District Court for the Eastern District of Texas is accepting applications for the position of Case Administrator. There are seven offices within the Eastern District of Texas: Beaumont, Lufkin, Marshall, Plano, Sherman, Texarkana... more
| Announcement
The United States District Court for the Eastern District of Texas is accepting applications for the position of Death Penalty Law Clerk. The continuation of this position is subject to the Fifth Circuit annual allocation of death penalty/pro se law... more
| Announcement
The Beaumont court house will delay opening until 10 a.m. on Thursday, June 22, 2017.
| Announcement
The Texarkana division of the United States District Clerk's Office for the Eastern District of Texas will have reduced hours on Monday, July 3, 2017, and will be open for business from 8:00 am until noon. All other divisions will be closed, subject... more
| Announcement
The Court has been informed of a new phishing scam that is making its way around the Internet. Click here for more information.
| Announcement
Effective June 1, 2017, a new civil nature of suit (NOS) code 835, Patent - Abbreviated New Drug Application (ANDA), will be used for patent cases involving companies seeking to market generic drugs by submitting the ANDA under the provisions of the... more